What changed in STERIS plc's latest annual report
In the year ended 31 Mar 2026, STERIS plc's revenue rose 8.7% to USD 5.94bn, from USD 5.46bn; net income rose 27.3% to USD 782.30m, from USD 614.60m; shareholders' equity rose 8.8% to USD 7.18bn, from USD 6.60bn.
Year ended 31 Mar 2026. Source: 10-K filed 29 May 2026, read it on SEC EDGAR.
USD 5.46bn to USD 5.94bn
The figures, year on year
| Item | Year before | Latest year | Change |
|---|---|---|---|
| Revenue | 5.46bn | 5.94bn | Up 8.7% |
| Net income | 614.60m | 782.30m | Up 27.3% |
| Total assets | 10.15bn | 10.74bn | Up 5.8% |
| Total liabilities | 3.53bn | 3.54bn | Up 0.3% |
| Long-term debt | 1.92bn | 1.81bn | Down 5.5% |
| Shareholders' equity | 6.60bn | 7.18bn | Up 8.8% |
Questions people ask
Did STERIS plc's revenue grow last year?
Revenue grew 8.7%, from USD 5.46bn to USD 5.94bn in the year ended 31 Mar 2026.
Is STERIS plc profitable?
Yes. Net income was USD 782.30m in the year ended 31 Mar 2026. The year before: USD 614.60m.
How much cash and debt does STERIS plc have?
At its latest year end (31 Mar 2026), STERIS plc reported long-term debt of USD 1.81bn.
Where do these numbers come from?
From STERIS plc's own annual filings with the SEC. Each change is calculated from the reported figures; nothing is estimated.
Meeting a client who works with STERIS plc?
LYNORIQ remembers every client meeting the way this page tracks a filing: what changed since last time, what you promised, and what they owe you.
Start free See the demoOther Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical, Inc.Cash and cash equivalents up 66.1%
- Edwards Lifesciences CorporationNet income down 74.3%
- Zimmer Biomet Holdings, Inc.Long-term debt up 29.8%
- Align Technology, Inc.Total liabilities down 7.5%